IMV Technologies Acquires UD-Vet B.V.

IMV Technologies Group Acquires Veterinary Solutions

May 31, 2023

Medical Devices

IMV Technologies Group has acquired Veterinary Solutions, a Belgium-based developer of veterinary digital radiography (DR X-Ray) systems and PACS software. Veterinary Solutions will join IMV's Companion Animal business to broaden IMV's veterinary imaging product range and strengthen its presence across Europe.

IMV Technologies Group Acquires Medivet Scandinavian AB

June 6, 2024

Medical Devices

IMV Technologies Group has acquired Medivet Scandinavian AB, a Sweden-based provider of veterinary DR X‑ray systems and other imaging modalities headquartered in Ängelholm. The acquisition expands IMV's companion animal imaging business and adds Medivet’s equine MERS X‑ray capability and Scandinavian market presence.

IMV Technologies Acquires VES Custom Optics (VESCO)

January 28, 2022

Medical Devices

IMV Technologies announced the acquisition of VES Custom Optics (VESCO), a UK-based supplier and service provider of veterinary rigid and flexible endoscopes. VESCO will be integrated into IMV imaging’s companion animal business to expand IMV’s veterinary endoscopy, service and training capabilities for small animal and equine customers in the UK and Ireland.

Avanti Equine Veterinary Partners Acquires Animal Imaging and Steinbeck Peninsula Equine Clinic

December 22, 2021

Veterinary

Avanti Equine Veterinary Partners acquired Irving, Texas–based Animal Imaging on December 22, 2021, marking Avanti's first location in Texas. The equine practice network also acquired California-based Steinbeck Peninsula Equine Clinic as part of its national expansion to provide management and operational and administrative support to partner practices.

IMV Technologies Acquires Genetirate

April 2, 2021

Biotechnology

French animal-reproduction specialist IMV Technologies has acquired Genetirate, a U.S.-based aquaculture biotechnology startup founded at the University of Arizona. The deal brings Genetirate's metabolic-rate sorting technology into IMV's portfolio to accelerate sustainable aquaculture production, particularly for salmon and trout.

Dechra Pharmaceuticals to Acquire Invetx

July 18, 2024

Biotechnology

Dechra Pharmaceuticals Limited has agreed to acquire Boston-based Invetx Inc., a developer of species-specific monoclonal antibody therapeutics for companion animals, for up to $520 million on a cash-free, debt-free basis, subject to customary approvals. The deal gives Dechra access to Invetx's pipeline and half-life extension platform to expand its specialty veterinary biologics capabilities.